-
A medical research unit in the United Kingdom analyzed 18 different strategies for managing patients with suspected deep vein thrombosis (DVT). Using systematic review, meta-analysis and cost effectiveness analysis, they settled on an algorithm based on clinical risk.
-
The FDA has licensed the first vaccine to prevent cancer due to human papillomaviruses (HPV) types 6, 11, 16, and 18, the most common subtypes of this prevalent virus.
-
Male pattern baldness is a result of the impact of dihydrotestosterone (DHT) upon scalp hair follicles which results in a progressive miniaturization of follicles leading to thinner, shorter hairs in genetically susceptible men.
-
Clinicians seem not to follow any of several recommended guidelines when evaluating and treating pharyngitis and, as a result, there is widespread over-treatment with antibiotics.
-
Testing and treating H. pylori and empirical PPI treatment similarly relieved symptoms in dyspeptic patients, but the 'test and treat' strategy resulted in lower endoscopic workload and decreased cost.
-
Chronic insomnia in older adults improved more with objective measures when treated with cognitive behavioral therapy rather than nightly medications.
-
The FDA has given an accelerated approval for a new protease inhibitor (PI) for the treatment of HIV infections. Darunavir (TMC114) is approved for patients who have shown resistance to more than one protease inhibitor.
-
The two non-sequential lead II rhythm strips shown in the image were interpreted as showing "sinus tachycardia (top strip) with sudden development of PSVT" (lower strip).
-
Cephalosporins should be considered for penicillin-allergic patients due to low cross-reactivity risk, but these patients do have a small increased risk of subsequent reactions to both sulfonamides and cephalosporins.
-
Black cohosh, when studied in appropriate randomized trials, is no different than placebo treatment in affecting hot flushing.
